Sponsor
Thomas Hope
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Thomas Hope appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownComparison of 177Lu-PSMA-617 and 225Ac-PSMA-617NCT07054346 · lead sponsor · 2025-07-08
RECRUITINGImaging of Solid Tumors Using DLL3 SPECTNCT07052760 · lead sponsor · 2026-04-30
WITHDRAWN68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate CancerNCT04716725 · lead sponsor · 2021-09-28
TERMINATEDGallium-68 PSMA-11 PET Imaging in Prostate Cancer PatientsNCT03803475 · lead sponsor · 2018-10-11
COMPLETEDGallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical RecurrenceNCT03353740 · lead sponsor · 2017-09-20
COMPLETEDEvaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer PatientsNCT02611882 · lead sponsor · 2015-12-18
COMPLETEDSponsor roles
lead sponsor6
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.